Michael H Silverman MD FACP

Rheumatology•Marblehead, MA

President and Senior Clinical Development Consultant, BioStrategics Consulting Ltd

Join to View Full Profile

51 Intrepid CircleBiostrategics Consulting LtdMarblehead, MA 01945
Phone+1 781-631-8596

Education & Training

University of ColoradoFellowship, Rheumatology, 1976 - 1978
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1973 - 1976
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1973

Certifications & Licensure

MA State Medical License 1993 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Clinical Trials

Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients Start of enrollment: 2006 Jun 01
Completed
Phase 2
A Trial of the Safety and Efficacy of EcoNail™ in the Treatment of Fungus Infections of the Great Toenail Start of enrollment: 2006 Sep 01
Completed
Phase 2
Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients Start of enrollment: 2008 Feb 01
Completed
Phase 2
A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma Start of enrollment: 2009 Feb 01
Completed
Phase 1, Phase 2
A Phase 1/2 Study of CF102 in Patients With Chronic Hepatitis C Genotype 1 Start of enrollment: 2009 Jul 01
Completed
Phase 1, Phase 2
A Study of the Efficacy and Safety of CF101 to Patients With Osteoarthritis of the Knee Start of enrollment: 2018 Nov 01
Withdrawn
Phase 2
Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure Start of enrollment: 2010 Oct 01
Completed
Phase 2
Oral CF101 Tablets Treatment in Patients With Rheumatoid Arthritis Start of enrollment: 2010 Oct 01
Completed
Phase 2
Trial of CF101 to Treat Patients With Dry Eye Disease Start of enrollment: 2011 Jul 01
Completed
Phase 3
Trial of CF101 to Treat Patients With Psoriasis Start of enrollment: 2011 Jul 01
Completed
Phase 2, Phase 3
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers Start of enrollment: 2014 Jun 01
Completed
Phase 3
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers Start of enrollment: 2014 Jun 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

13 citations
A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with...
Sharad A. Ghamande, Chia-Chi Lin, Daniel C. Cho, Geoffrey I. Shapiro, Eunice L. Kwak
Investigational New Drugs. 2014-06-01
1 citations
Continuous safety monitoring for randomized controlled clinical trials with blinded treatment information. Part 3: Design considerations.
Greg Ball, Michael H Silverman
Contemporary Clinical Trials. 2011-09-01
Continuous safety monitoring for randomized controlled clinical trials.
Linda B. Piller, Michael H. Silverman, Greg Ball
Contemporary Clinical Trials. 2011-09-01

Professional Memberships

American College of Physicians - ACP
Fellow

Michael H Silverman MD FACP

Dr. Silverman is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.